Skip to main content

Rabbit Polyclonal RPL39 antibody. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 2 publications.

Be the first to review this product! Submit a review

Images

Western blot - Anti-RPL39 antibody (AB74740), expandable thumbnail

Publications

Key facts

Isotype
IgG
Host species
Rabbit
Storage buffer

pH: 7.4
Preservative: 0.02% Sodium azide
Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.87% Sodium chloride

Form
Liquid
Clonality
Polyclonal

Immunogen

  • The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

Select an application
Product promiseTestedExpectedPredictedNot recommended
WBICC/IF
Human
Tested
Tested
Mouse
Predicted
Predicted
Rat
Predicted
Predicted

Tested
Tested

Species
Human
Dilution info
1/500 - 1/1000
Notes

-

Predicted
Predicted

Species
Mouse, Rat
Dilution info
-
Notes

-

Tested
Tested

Species
Human
Dilution info
1/500 - 1/1000
Notes

-

Predicted
Predicted

Species
Mouse, Rat
Dilution info
-
Notes

-

Target data

Function

RNA-binding component of the large ribosomal subunit. The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell.

Alternative names

Recommended products

Rabbit Polyclonal RPL39 antibody. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 2 publications.

Key facts

Isotype
IgG
Form
Liquid
Clonality
Polyclonal
Immunogen
  • The exact immunogen used to generate this antibody is proprietary information.
Purification technique
Affinity purification Immunogen
Concentration
Loading...
Purification notes

ab74740 was affinity purified from rabbit antiserum by affinity chromatography using epitope specific immunogen.

Storage

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Notes

Abcam is leading the way to address reproducibility in scientific research with our highly validated recombinant monoclonal and recombinant multiclonal antibodies. Search & select one of Abcam's thousands of recombinant alternatives to eliminate batch-variability and unnecessary animal use.

If you do not find a host species to meet your needs, our catalogue and custom Chimeric range provides scientists the specificity of Abcam's RabMAbs in the species backbone of your choice. Remember to also review our range of edited cell lines, proteins and biochemicals relevant to your target that may help you further your research goals.

Abcam antibodies are extensively validated in a wide range of species and applications, so please check the reagent specifications meet your scientific needs before purchasing. If you have any questions or bespoke requirements, simply visit the Contact Us page to send us an inquiry or contact our Support Team ahead of purchase.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

RPL39 also known as Ribosomal Protein L39 is a component of the ribosome the cell's protein synthesis machinery. It has a small molecular mass of around 6 kilodaltons. This protein is ubiquitously expressed in many tissues indicating its importance in cellular function. As part of the ribosomal subunits RPL39 plays a mechanical role in facilitating mRNA translation by ensuring the proper assembly and function of the ribosome.

Biological function summary

RPL39 contributes significantly to the protein synthesis process. It forms part of the large 60S subunit of the ribosome which requires it for effective translation and expansion of the polypeptide chain. In the ribosomal complex RPL39 supports the stability and proper function of the ribosome enabling proper decoding of genetic information. Its interaction with other ribosomal proteins ensures the continual and efficient production of proteins needed for basic cellular processes.

Pathways

The role of RPL39 is essential in the translation pathway a core part of the central dogma of molecular biology. Within this pathway RPL39 interacts with other ribosomal proteins such as RPL10 and RPL5 to facilitate the synthesis of proteins. Additionally it associates with the mTOR signaling pathway influencing cell growth and protein synthesis regulation and works closely with mTOR complex proteins like Raptor to modulate the rate of translation in response to various stimuli.

Associated diseases and disorders

RPL39 has notable implications in cancer and embryonic development anomalies. Abnormal expression of RPL39 has been linked to the progression of certain cancers such as lung and breast cancers. This connection often involves interactions with c-Myc a protein whose dysregulation is common in several cancer types further intensifying tumor growth and progression. Additionally mutations in RPL39 have been associated with Diamond-Blackfan Anemia a disorder characterized by faulty ribosome function revealing its important role in maintaining proper blood cell production through its interaction with other ribosomal proteins.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

1 product image

  • Western blot - Anti-RPL39 antibody (ab74740), expandable thumbnail

    Western blot - Anti-RPL39 antibody (ab74740)

    All lanes: Western blot - Anti-RPL39 antibody (ab74740) at 1/500 dilution

    Lane 1: HepG2 cell extracts at 30 µg

    Lane 2: COLO cell extracts at 30 µg

    Lane 3: COLO cell extracts at 30 µg with immunising peptide

    Predicted band size: 7 kDa

    Observed band size: 7 kDa

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com